Vimarsana
Biggest News Aggregation in the World

Page 5 - Albert Cha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Albert Cha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Albert Cha Today - Breaking & Trending Today

Silence Therapeutics PLC welcomes new US institutional investor Frazier Life Sciences - Vimarsana News

Silence Therapeutics PLC welcomes new US institutional investor Frazier Life Sciences

Frazier Life Sciences managing partner Albert Cha said the firm “is excited for the prospects for Silence's RNA interference platform...

Do Hedge Funds Love Cullinan Oncology, Inc. (CGEM)? - Vimarsana News

Do Hedge Funds Love Cullinan Oncology, Inc. (CGEM)?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Were Hedge Funds Right About ASLAN Pharmaceuticals Limited (ASLN)? - Vimarsana News

Were Hedge Funds Right About ASLAN Pharmaceuticals Limited (ASLN)?

Were Hedge Funds Right About ASLAN Pharmaceuticals Limited (ASLN)? Is ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. The top picks of these firms have historically outperformed the market when we account for known risk factors, making them very valuable investment ideas. ASLAN Pharmaceuticals...

Ascendis Pharma A/S Announces Planned Board Transition - Vimarsana News

Ascendis Pharma A/S Announces Planned Board Transition

Share: – Chair and board member Michael Wolf Jensen will not stand for re-election at 2021 Annual General Meeting – – Board of Directors intends to appoint Dr. Albert Cha to serve as Chair after 2021 AGM – COPENHAGEN, Denmark, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced a planned board transition at the 2021 Annual General Meeting (AGM). Michael Wolf Jensen informed the Board of Directors (the Board)...